Published in J Exp Med on July 01, 1984
Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39
Plaque formation in agar by single antibody-producing cells. Science (1963) 17.94
A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol (1976) 9.11
Affinity labeling of a phosphorylcholine binding mouse myeloma protein. Biochemistry (1972) 4.26
T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. Proc Natl Acad Sci U S A (1980) 3.08
Cellular and genetic control of antibody responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells. J Exp Med (1979) 2.75
Collaboration of allogeneic T and B lymphocytes in the primary antibody response to sheep erythrocytes in vitro. J Exp Med (1975) 2.30
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide. J Immunol (1976) 1.86
Antigen-specific stimulation and trans-stimulation of T cells in long-term culture. Eur J Immunol (1979) 1.52
An analysis of the defective response of CBA/N mice to T-dependent antigens. J Immunol (1975) 1.45
H-2-restricted T-B cell interactions involved in polyspecific B cell responses mediated by soluble antigen. Eur J Immunol (1982) 1.39
Contribution of Lyb 5+ and Lyb 5- B cells to the primary and secondary phosphocholine-specific antibody response. J Immunol (1983) 1.09
A requirement for two cell types for antibody formation in vitro. Science (1967) 8.91
E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell (1994) 5.41
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J (1996) 5.17
Cell interactions in the primary immune response in vitro: a requirement for specific cell clusters. J Exp Med (1969) 3.38
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science (1999) 3.10
Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med (1985) 2.87
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity (1999) 2.67
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Ontogeny of mouse lymphocyte function. II. Development of the ability to produce antibody is modulated by T lymphocytes. J Exp Med (1975) 2.49
Both E12 and E47 allow commitment to the B cell lineage. Immunity (1997) 2.27
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur J Immunol (1978) 2.13
The rate of division of antibody-forming cells during the early primary immune response. J Exp Med (1968) 2.10
Cellular requirements for the primary in vitro antibody response to DNP-ficoll. J Exp Med (1974) 2.10
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol (1977) 2.03
Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations. J Virol (2006) 2.00
Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J Exp Med (1987) 2.00
E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol Cell (2000) 1.99
Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice. J Exp Med (1978) 1.89
Mice whose B cells cannot produce the T15 idiotype also lack an antigen-specific helper T cell required for T15 expression. J Exp Med (1979) 1.86
In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide. J Immunol (1976) 1.86
Functional maturation of thymic lymphocyte populations in vitro. J Exp Med (1972) 1.76
Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody. Eur J Immunol (1980) 1.62
Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium. J Immunol (1981) 1.61
Cellular deficit in thymectomized mice. Nature (1970) 1.57
Pneumococcal polysaccharides induce antibody formation by human B lymphocytes in vitro. J Immunol (1985) 1.55
Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci U S A (1998) 1.50
In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice. J Immunol (1976) 1.50
Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J Exp Med (2001) 1.47
The role of surface IgD in the response to thymic-independent antigens. J Exp Med (1977) 1.46
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
Ontogeny of mouse lymphocyte function. I. Paradoxical elevation of reactivity to allogeneic cells and phytohemagglutinin in BALB-c fetal thymocytes. J Immunol (1974) 1.39
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med (1978) 1.37
Animal models for retrovirus-induced immunodeficiency disease. Immunol Invest (1986) 1.34
Ly phenotype and mechanism of action of mouse neonatal suppressor T cells. J Exp Med (1977) 1.33
hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev (1991) 1.29
Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency. J Exp Med (1991) 1.23
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. J Immunol (1976) 1.19
HIV results in the frame. CD4+ cell turnover. Nature (1995) 1.19
Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression. J Virol (2001) 1.15
The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol (1998) 1.15
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol (1990) 1.14
Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J Immunol (1983) 1.11
Individual V(H) promoters vary in strength, but the frequency of rearrangement of those V(H) genes does not correlate with promoter strength nor enhancer-independence. Mol Immunol (2000) 1.07
The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells. J Exp Med (1990) 1.07
Sequence of the spacer in the recombination signal sequence affects V(D)J rearrangement frequency and correlates with nonrandom Vkappa usage in vivo. J Exp Med (1998) 1.04
Limited junctional diversity in kappa light chains. Junctional sequences from CD43+B220+ early B cell progenitors resemble those from peripheral B cells. J Immunol (1994) 1.04
Nucleotide deletion and P addition in V(D)J recombination: a determinant role of the coding-end sequence. Mol Cell Biol (1997) 1.04
Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J Exp Med (1984) 1.04
Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype. J Virol (2009) 1.02
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol (1997) 1.01
Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine. J Immunol (1988) 1.01
Influence of coding-end sequence on coding-end processing in V(D)J recombination. J Immunol (1995) 1.01
Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol (1989) 1.01
Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J Infect Dis (1977) 1.00
Immunologic effects of neonatal infection with mouse thymic virus. J Immunol (1975) 1.00
Lyb antigens and their role in B lymphocyte activation. Immunol Rev (1982) 0.99
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J Immunol (1999) 0.98
Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res (1992) 0.97
Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. J Virol (1997) 0.97
Cell-cell interactions in antibody production. Prog Allergy (1972) 0.95
On the SCIDs? Nature (1989) 0.95
The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology (1997) 0.94
LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. Inability to recognize a putative viral superantigen does not prevent induction of disease. J Immunol (1993) 0.93
Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens. J Immunol (1978) 0.93
Separation of macrophages on plastic and glass surfaces. Methods Enzymol (1984) 0.92
The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol (1996) 0.92
Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist. J Immunol (1996) 0.92
Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol (1995) 0.91
Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. J Virol (1997) 0.90
New alleles of IGKV genes A2 and A18 suggest significant human IGKV locus polymorphism. Immunogenetics (1996) 0.90
Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics (1982) 0.90
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy. J Acquir Immune Defic Syndr (2000) 0.90
Sequences of four new members of the VH7183 gene family in BALB/c mice. Immunogenetics (1994) 0.89
Ontogeny of mouse T-lymphocyte function. Fed Proc (1975) 0.89
CD4+CD8- thymocytes from neonatal mice induce IgM production in SCID mice. J Immunol (1992) 0.89
Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol (1992) 0.87
Coding end processing is similar throughout ontogeny. J Immunol (1995) 0.86
Early modification of host cell gene expression induced by HIV-1. AIDS (1998) 0.86
Analysis of homology-directed recombination in VDJ junctions from cytoplasmic Ig- pre-B cells of newborn mice. J Immunol (1995) 0.85
Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leuk Res (1992) 0.85
Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate. AIDS Res Hum Retroviruses (1991) 0.84
Reactivity of steroid-resistant neonatal thymocytes. Nature (1974) 0.84
Maturation of reactivity to histocompatibility antigens. Transplant Proc (1972) 0.83
Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol (1994) 0.83
Cellular requirements for antigen presentation in the induction of a thymus-independent antibody response in vitro. J Immunol (1980) 0.83
Immunobiology of Epstein-Barr virus-associated lymphomas. Clin Immunol Immunopathol (1994) 0.82
Negative selection in vivo reveals expression of strong Mls determinants in mice with X-linked immunodeficiency. J Exp Med (1984) 0.82
CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis. J Immunol (1997) 0.82
Role of homology-directed recombination: predominantly productive rearrangements of Vh81X in newborns but not in adults. Mol Immunol (1993) 0.81
Antigen-specific helper T cells required for dominant idiotype expression are not H-2 restricted. J Exp Med (1981) 0.81
Cell cooperation during in vivo anti-hapten antibody responses. VI. Evidence for an allogeneic effect replacing one of two helper T cells. Eur J Immunol (1980) 0.81
Distribution of human kappa locus IGKV2-29 and IGKV2D-29 alleles in Swedish Caucasians and Hong Kong Chinese. Immunogenetics (2001) 0.81
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res (1999) 0.80